EIG
TWST icon

EdgePoint Investment Group’s Twist Bioscience TWST Stock Holding History

EdgePoint Investment Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$256M Buy
5,382,521
+4,530
+0.1% +$203K 2.05% 18
2025
Q4 		$171M Buy
5,377,991
+1,295,672
+32% +$40.4M 1.4% 17
2025
Q3 		$115M Buy
4,082,319
+1,696,377
+71% +$51.4M 0.86% 22
2025
Q2 		$87.8M Buy
2,385,942
+1,272,732
+114% +$44M 0.66% 24
2025
Q1 		$43.7M Buy
+1,113,210
New +$50.1M 0.35% 30

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EdgePoint Investment Group's TWST Position: Q1 2026 in Review

EdgePoint Investment Group increased its Twist Bioscience (TWST) stake by 0.08% in Q1 2026, buying an estimated $203K and bringing the position to 5,382,521 shares worth $256M. The position accounts for 2.05% of the portfolio, ranked #18.

EdgePoint Investment Group first reported a position in TWST in Q1 2025 and has held it in 5 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • EdgePoint Investment Group held 5,382,521 shares of Twist Bioscience worth $256M as of Q1 2026.
  • EdgePoint Investment Group bought 4,530 Twist Bioscience shares in Q1 2026, an estimated $203K.
  • Twist Bioscience made up 2.05% of EdgePoint Investment Group's portfolio in Q1 2026, its #18 holding.
  • EdgePoint Investment Group first reported a position in Twist Bioscience in Q1 2025 and has held it in 5 quarters since.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on EdgePoint Investment Group's 13F filing for Q1 2026, filed 15 May 2026.